Real-time biomedical studies possible through one of the world's largest ocular research centres

Article

Real-time biomedical studies of factors leading to vision impairment are now possible through one of the world's largest ocular research centre at Lions Eye Institute for Transplant & Research.

Real-time biomedical studies of factors leading to vision impairment are now possible through one of the world's largest ocular research centre at Lions Eye Institute for Transplant & Research. As the first research centre in the world to be directly combined with an eye bank, the Ocular Research Centre provides a repository of healthy and diseased ocular tissue for researchers from academic institutions, government organizations and the pharmaceutical industry.

For the first time, researchers can study the complete picture of health through tissue, medical history and family information, which will improve the understanding of underlying health factors leading to vision impairment and blindness. These studies will drive the development of new diagnostic tests and pharmacologic treatments for delaying, stopping and preventing progression of ocular diseases and conditions.

Over the past 30 years, Lions Eye Institute for Transplant & Research has provided 50,000 eyes for research and given the gift of sight through cornea transplantation to more than 30,000 men, women and children worldwide.“The Ocular Research Centre recently established a relationship with Emory University and we look forward to forming relationships with other organizations to accelerate drug innovation, provide timely clinical trials and formalize best practices,” said Jason Woody, Lions Eye Institute for Transplant & Research CEO.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.